DalsnaFinance

Candel Therapeutics initiates phase 3 lung cancer trial

Markets Investing.com By Investing.com 30 Jun 2026 12:12 1 min read
Candel Therapeutics initiates phase 3 lung cancer trial

Candel Therapeutics initiates phase 3 lung cancer trial

Candel Therapeutics initiates phase 3 lung cancer trial

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.